The production value of biotechnology research and experimental development in Austria peaked in 2015 with 438.4 million Euros. Since 2018, there has been a consistent decline, with the value standing at 195.6 million Euros in 2023—a 3.74% decrease from the previous year and a notable decline from the peak. From 2019 to 2023, the sector experienced consecutive negative year-on-year variations, highlighting a challenging period for the industry. The Compound Annual Growth Rate (CAGR) over the last five years shows a decrease of approximately 1.31%, indicating a steady contraction.

Looking ahead, the forecast indicates a persistent downward trend with an anticipated average annual reduction of 3.38% from 2024 to 2028, culminating in a production value of 158.4 million Euros by 2028, marking a 15.79% drop over five years.

Future trends to watch for:

Potential policy changes or funding initiatives aimed at revitalizing the sector.
Innovations in biotechnology that might spark renewed growth and investment.
Global market conditions influencing the local industry, such as technological advancements or regulatory changes.